WV SB723

Clinical inpatient medical treatment centers for substance use disorder in West Virginia must maintain at least 85% of patients as state residents (defined as living in WV for 60 days prior to admission), evaluated quarterly

Centers must transition 100% of graduates via "warm handoff" to appropriate care levels, with at least 70% placed in certified recovery residences unless documented as unavailable

All centers must offer an integrated care model including health screenings, HIV/hepatitis/STD testing, vaccinations, birth control options, basic diagnostics, treatment of common illnesses, and overdose prevention education—all provided onsite, not via telehealth or referral

Each patient must receive a dental evaluation and routine cleaning before discharge, 30 days of medication upon discharge (excluding methadone, buprenorphine, or naltrexone), and assessment for job readiness programs including assistance obtaining identification documents

Centers must submit quarterly reports to the Office of the Inspector General tracking residency percentages, placement rates, length of stay, readmission rates, and other metrics, with non-compliance resulting in a six-month improvement period followed by potential license revocation; effective October 1, 2025